BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 31849857)

  • 1. EHV-1: A Constant Threat to the Horse Industry.
    Oladunni FS; Horohov DW; Chambers TM
    Front Microbiol; 2019; 10():2668. PubMed ID: 31849857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmasking the ongoing challenge of equid herpesvirus- 1 (EHV-1): A comprehensive review.
    Afify AF; Hassanien RT; El Naggar RF; Rohaim MA; Munir M
    Microb Pathog; 2024 Jun; 193():106755. PubMed ID: 38897362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine Herpesvirus Type 1 Enhances Viral Replication in CD172a+ Monocytic Cells upon Adhesion to Endothelial Cells.
    Laval K; Favoreel HW; Poelaert KC; Van Cleemput J; Nauwynck HJ
    J Virol; 2015 Nov; 89(21):10912-23. PubMed ID: 26292328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1.
    Laval K; Poelaert KCK; Van Cleemput J; Zhao J; Vandekerckhove AP; Gryspeerdt AC; Garré B; van der Meulen K; Baghi HB; Dubale HN; Zarak I; Van Crombrugge E; Nauwynck HJ
    Front Microbiol; 2021; 12():662686. PubMed ID: 33746936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the immune response to the pathogenesis of equine herpesvirus-1 (EHV-1): Are there immune correlates that predict increased risk or protection from EHV-1 myeloencephalopathy?
    Hussey GS; Giessler KS
    Vet J; 2022 Apr; 282():105827. PubMed ID: 35405348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
    Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equine herpesvirus 1 myeloencephalopathy.
    Wilson WD
    Vet Clin North Am Equine Pract; 1997 Apr; 13(1):53-72. PubMed ID: 9106343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine Herpesvirus-1 Myeloencephalopathy.
    Pusterla N; Hussey GS; Goehring LS
    Vet Clin North Am Equine Pract; 2022 Aug; 38(2):339-362. PubMed ID: 35811201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of equid herpesvirus 1 for the veterinary practitioner. Part B: pathogenesis and epidemiology.
    Dunowska M
    N Z Vet J; 2014 Jul; 62(4):179-88. PubMed ID: 24597839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equine Herpesvirus-1 Myeloencephalopathy, an Emerging Threat of Working Equids in Ethiopia.
    Negussie H; Gizaw D; Tessema TS; Nauwynck HJ
    Transbound Emerg Dis; 2017 Apr; 64(2):389-397. PubMed ID: 26010868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky.
    Allen GP; Bolin DC; Bryant U; Carter CN; Giles RC; Harrison LR; Hong CB; Jackson CB; Poonacha K; Wharton R; Williams NM
    Equine Vet J; 2008 Mar; 40(2):105-10. PubMed ID: 18089469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood Mononuclear Cells in Horses during Equine Herpesvirus 1 Infection.
    Zarski LM; Weber PSD; Lee Y; Soboll Hussey G
    Pathogens; 2021 Jan; 10(1):. PubMed ID: 33430330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of equid herpesvirus 1 for the veterinary practitioner. Part A: clinical presentation, diagnosis and treatment.
    Dunowska M
    N Z Vet J; 2014 Jul; 62(4):171-8. PubMed ID: 24597778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of Detection of Respiratory Pathogens in Clinically Healthy Show Horses Following a Multi-County Outbreak of Equine Herpesvirus-1 Myeloencephalopathy in California.
    Wilcox A; Barnum S; Wademan C; Corbin R; Escobar E; Hodzic E; Schumacher S; Pusterla N
    Pathogens; 2022 Oct; 11(10):. PubMed ID: 36297218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gB and pUS3 in Equine Herpesvirus 1 Transfer between Peripheral Blood Mononuclear Cells and Endothelial Cells: a Dynamic In Vitro Model.
    Spiesschaert B; Goldenbogen B; Taferner S; Schade M; Mahmoud M; Klipp E; Osterrieder N; Azab W
    J Virol; 2015 Dec; 89(23):11899-908. PubMed ID: 26378176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pathogenesis of acute equine herpesvirus 1 (EHV-1) infection in the horse and the mouse model: a review.
    Walker C; Love DN; Whalley JM
    Vet Microbiol; 1999 Aug; 68(1-2):3-13. PubMed ID: 10501157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equine Herpesvirus-I Infection in Horses: Recent Updates on its Pathogenicity, Vaccination, and Preventive Management Strategies.
    Khusro A; Aarti C; Rivas-Caceres RR; Barbabosa-Pliego A
    J Equine Vet Sci; 2020 Apr; 87():102923. PubMed ID: 32172913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equine herpesvirus 1 myeloencephalopathy.
    Pusterla N; Hussey GS
    Vet Clin North Am Equine Pract; 2014 Dec; 30(3):489-506. PubMed ID: 25300635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of viral loads, strain and state of equine herpesvirus-1 using real-time PCR in horses following natural exposure at a racetrack in California.
    Pusterla N; Wilson WD; Mapes S; Finno C; Isbell D; Arthur RM; Ferraro GL
    Vet J; 2009 Feb; 179(2):230-9. PubMed ID: 18024200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Surveillance of EHV-1 Strains Circulating in France during and after the Major 2009 Outbreak in Normandy Involving Respiratory Infection, Neurological Disorder, and Abortion.
    Sutton G; Garvey M; Cullinane A; Jourdan M; Fortier C; Moreau P; Foursin M; Gryspeerdt A; Maisonnier V; Marcillaud-Pitel C; Legrand L; Paillot R; Pronost S
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31590336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.